Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Preoperative Anxiety on ED50 and ED95 of Remimazolam for Loss of Consciousness in Hysteroscopy
ChiCTR2500115641Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in preoperative anxiety and procedural pain and anxiety associated with hysteroscopy (3 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: ED50 and ED95 of remimazolam for loss of consciousness. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
preoperative anxietyprocedural pain and anxiety associated with hysteroscopy
Beyond the preview
Go deeper on ChiCTR2500115641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115641.